Bo Chen

Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Failure patterns and clinical indications in early-stage follicular lymphoma: a study from the National Cancer Center in China.

Failure patterns and clinical indications in early-stage follicular lymphoma: a study from the National Cancer Center in China.

Journal: Frontiers in pharmacology

Published: November 12, 2025

Association of age and primary treatment with risk of non-lymphoma-related death and long-term survival outcomes in adult patients with early-stage follicular lymphoma: a population-based analysis.

Association of age and primary treatment with risk of non-lymphoma-related death and long-term survival outcomes in adult patients with early-stage follicular lymphoma: a population-based analysis.

Journal: Annals of hematology

Published: October 07, 2025

Postoperative chemoradiotherapy with capecitabine and oxaliplatin vs. capecitabine for pathological stage N2 rectal cancer.

Postoperative chemoradiotherapy with capecitabine and oxaliplatin vs. capecitabine for pathological stage N2 rectal cancer.

Journal: Chinese journal of cancer research = Chung-kuo yen cheng yen chiu

Published: June 01, 2024

Chinese expert consensus on refined diagnosis, treatment, and management of advanced primary liver cancer (2023 edition).

Chinese expert consensus on refined diagnosis, treatment, and management of advanced primary liver cancer (2023 edition).

Journal: Liver research (Beijing, China)

Published: April 12, 2024

Silencing of spindle apparatus coiled-coil protein 1 suppressed the progression of hepatocellular carcinoma through farnesyltransferase-beta and increased drug sensitivity.

Silencing of spindle apparatus coiled-coil protein 1 suppressed the progression of hepatocellular carcinoma through farnesyltransferase-beta and increased drug sensitivity.

Journal: Heliyon

Published: December 22, 2023

The cumulative antitumor effects of regorafenib and radiotherapy in hepatocellular carcinoma.

The cumulative antitumor effects of regorafenib and radiotherapy in hepatocellular carcinoma.

Journal: Molecular carcinogenesis

Published: December 13, 2023

Long-term outcome of centrally located hepatocellular carcinoma treated by neoadjuvant radiotherapy and radical resection: a propensity score matched study.

Long-term outcome of centrally located hepatocellular carcinoma treated by neoadjuvant radiotherapy and radical resection: a propensity score matched study.

Journal: Annals of medicine and surgery (2012)

Published: October 11, 2023

Anlotinib in the treatment of advanced hepatocellular carcinoma: an open-label phase II study (ALTER-0802 study).

Anlotinib in the treatment of advanced hepatocellular carcinoma: an open-label phase II study (ALTER-0802 study).

Journal: Hepatology international

Published: December 18, 2020

Optimal postoperative adjuvant treatment strategy for HBV-related hepatocellular carcinoma with microvascular invasion: a propensity score analysis.

Optimal postoperative adjuvant treatment strategy for HBV-related hepatocellular carcinoma with microvascular invasion: a propensity score analysis.

Journal: OncoTargets and therapy

Published: March 14, 2019

Showing 1-9 of 9

Last Updated: 09/26/2026